Skip to main content
. 2013 Nov 19;36(1):172–181. doi: 10.1007/s11096-013-9876-7

Fig. 4.

Fig. 4

Kaplan–Meier survival curves comparing the probability of survival between adherence and non-adherence groups. Adherence: patients’ imatinib medication possession ratio (MPR) > 90 %; non-adherence: patients’ MPR ≤ 90 %. * Numerator: number of patients survived in the patient-year; Denominator: number of patients contributing to the patient-year